ONCOMIP

Réseau de cancérologie de Midi-Pyrénées

FAQ

La prise en charge thérapeutique après le diagnostic

Q01. Question sur thumorothèque ?
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Why do we use it?

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved over the years, sometimes by accident, sometimes on purpose (injected humour and the like).
Accès réservé aux professionnels
Dossier Communicant
de Cancérologie : Se connecter
Dossier Patient GENEPY : Se connecter
Effectuez une recherche sur le site
 

AVERTISSEMENT

Conditions d'accès au Dossier Communicant de Cancérologie

L'accès au Dossier Communicant de Cancérologie est réservé aux professionnels de santé, médecin ou pharmacien ayant signé la charte des utilisateurs.

Fermer
 

Dernière modification de la page : 3 février 2016

 

Ce site respecte les principes de la charte HONcode de HONCe site respecte les principes de la charte HONcode.

Vérifiez ici.